Global deletion of Optineurin results in altered type I IFN signaling and abnormal bone remodeling in a model of Paget’s disease
Open accessThe DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Abstract
Genome-wide association studies (GWAS) have identified Optineurin (OPTN) as genetically linked to Paget's disease of the bone (PDB), a chronic debilitating bone remodeling disorder characterized by localized areas of increased bone resorption and abnormal bone remodeling. However, only ~10% of mouse models with a mutation in Optn develop PDB, thus hindering the mechanistic understanding of the OPTN-PDB axis. Here, we reveal that 100% of aged Optn global knockout (Optn-/-) mice recapitulate the key clinical features observed in PDB patients, including polyostotic osteolytic lesions, mixed-phase lesions, and increased serum levels of alkaline phosphatase (ALP). Differentiation of primary osteoclasts ex vivo revealed that the absence of Optn resulted in an increased osteoclastogenesis. Mechanistically, Optn-deficient osteoclasts displayed a significantly decreased type I interferon (IFN) signature, resulting from both defective production of IFNβ and impaired signaling via the IFNα/βR, which acts as a negative feedback loop for osteoclastogenesis and survival. These data highlight the dual roles of OPTN in the type I IFN response to restrain osteoclast activation and bone resorption, offering a novel therapeutic target for PDB. Therefore, our study describes a novel and essential mouse model for PDB and define a key role for OPTN in osteoclast differentiation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Mechanistically, OPTN deficiency maps to defective IFNB1/IFNβ1 (interferon beta 1) production and signaling, in turn linked to enhanced osteoclast differentiation and survival (Wong et al, 2020).”
From Autophagy in major human diseases (2021) · cites this paper as Wong et al, 2020
The cited source says what the claim attributes to it.
In the citing paper
“Recently, genetic ablation of Optn in mice has been found to recapitulate the clinical features observed in human PBD patients.”
From Autophagy in major human diseases (2021) · cites this paper as Wong et al, 2020
In the citing paper
“Bone lesions similar to PDB observed in patients, linked to increased osteoclastogenic potential and decreased type I IFN production”
From Autophagy in major human diseases (2021) · cites this paper as Wong et al (2020)
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Repertoires of Autophagy in the Pathogenesis of Ocular Diseases
Li, Y.-J., Jiang, Q., Cao, G.-F., Yao, J., & Yan, B. (2015) · Cellular Physiology and Biochemistry · doi:10.1159/000373980 · Cited by 16,304
Regulation of type I interferon responses
Ivashkiv, L. B., & Donlin, L. T. (2014) · Nature Reviews Immunology · doi:10.1038/nri3581 · Cited by 3,297
Men and mice: Relating their ages
Dutta, S., & Sengupta, P. (2016) · Life Sciences · doi:10.1016/j.lfs.2015.10.025 · Cited by 1,710
RANKL maintains bone homeostasis through c-Fos-dependent induction of interferon-β
Takayanagi, H., Kim, S., Matsuo, K., Suzuki, H., Suzuki, T., Sato, K., Yokochi, T., Oda, H., Nakamura, K., Ida, N., et al. (2002) · Nature · doi:10.1038/416744a · Cited by 717
RIPK1 mediates axonal degeneration by promoting inflammation and necroptosis in ALS
Ito, Y., Ofengeim, D., Najafov, A., Das, S., Saberi, S., Li, Y., Hitomi, J., Zhu, H., Chen, H., Mayo, L., et al. (2016) · Science · doi:10.1126/science.aaf6803 · Cited by 606
RIPK1 Blocks Early Postnatal Lethality Mediated by Caspase-8 and RIPK3
Dillon, C. P., Weinlich, R., Rodriguez, D. A., Cripps, J. G., Quarato, G., Gurung, P., Verbist, K. C., Brewer, T. L., Llambi, F., Gong, Y.-N., et al. (2014) · Cell · doi:10.1016/j.cell.2014.04.018 · Cited by 562
SOCS: physiological suppressors of cytokine signaling
Krebs, D. L., & Hilton, D. J. (2000) · Journal of Cell Science · doi:10.1242/jcs.113.16.2813 · Cited by 463
Osteoarthritis severity is sex dependent in a surgical mouse model
Ma, H.-L., Blanchet, T. J., Peluso, D., Hopkins, B., Morris, E. A., & Glasson, S. S. (2007) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2006.11.005 · Cited by 377
NF-κB signaling and bone resorption
Abu-Amer, Y. (2013) · Osteoporosis International · doi:10.1007/s00198-013-2313-x · Cited by 340
Roodman, G. D., & Windle, J. J. (2005) · Journal of Clinical Investigation · doi:10.1172/jci24281 · Cited by 340
Research works printed but not linked: 1
- Albagha OM. Genetics of Paget’s disease of bone. Bone Rep. 2015;4:756.
Cited by
Autophagy in major human diseases
Klionsky, D. J., Petroni, G., Amaravadi, R. K., Baehrecke, E. H., Ballabio, A., Boya, P., Bravo‐San Pedro, J. M., Cadwell, K., Cecconi, F., Choi, A. M. K., et al. (2021) · The EMBO Journal · doi:10.15252/embj.2021108863 · Cited by 1,585
Self-citationLiu, Z.-Z., Hong, C.-G., Hu, W.-B., Chen, M.-L., Duan, R., Li, H.-M., Yue, T., Cao, J., Wang, Z.-X., Chen, C.-Y., et al. (2021) · Autophagy · doi:10.1080/15548627.2020.1839286 · Cited by 163
Self-citationEmerging views of OPTN (optineurin) function in the autophagic process associated with disease
Qiu, Y., Wang, J., Li, H., Yang, B., Wang, J., He, Q., & Weng, Q. (2022) · Autophagy · doi:10.1080/15548627.2021.1908722 · Cited by 134
OPTN is a host intrinsic restriction factor against neuroinvasive HSV-1 infection
Ames, J. M., Yadavalli, T., Suryawanshi, R. K., Hopkins, J., Agelidis, A. M., Patil, C. D., Fredericks, B., Tseng, H. C., Vályi-Nagy, T., & Shukla, D. (2021) · Nature Communications · doi:10.1038/s41467-021-25642-z · Cited by 71
Self-citationDopamine suppresses osteoclast differentiation via cAMP/PKA/CREB pathway
Wang, L., Han, L., Xue, P., Hu, X., Wong, S., Deng, M., Tseng, H. C., Huang, B., & Ko, C. (2020) · Cellular Signalling · doi:10.1016/j.cellsig.2020.109847 · Cited by 60
Self-citation
Metadata
- Authors
- Wong, S.-W., Huang, B.-W., Hu, X., Ho Kim, E., Kolb, J. P., Padilla, R. J., Xue, P., Wang, L., Oguin, T. H., Miguez, P. A., Tseng, H. C., Ko, C.-C., & Martinez, J.
- Affiliations
- University of North Carolina at Chapel Hill (US)
- National Institutes of Health (US)
- Duke Medical Center (US)
- Corresponding author
- Martinez, Jennifer
- ORCID
- Venue
- Cell Death & Differentiation
- Published
- 2019-05-10
- Volume
- 27
- Issue
- 1
- Pages
- 71-84
- ISSN
- 1350-9047 (ISSN-L)
- 1476-5403
- PMC
- PMC7205997
- OpenAlex
- W4241869175
- Cited by
- 42
- References
- 41
- Citations by year
- 2026: 4 · 2025: 3 · 2024: 8 · 2023: 5 · 2022: 6 · 2021: 8 · 2020: 7
- FWCI
- 1.74
- Type
- journal article
- Language
- en
- Update notices
- correction (2020-07-16)
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Cell Death and Differentiation (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Carolina Digital Repository (University of North Carolina at Chapel Hill) (submittedVersion)
- UNC Libraries
- Funders
- U.S. Department of Health & Human Services | NIH | National Institute of Environmental Health Sciences (1ZIAES10328601)
- U.S. Department of Health & Human Services | NIH | National Institute of Dental and Craniofacial Research (R90DE022527, R01DE022816)
- U.S. Department of Health & Human Services | NIH | National Eye Institute (K08-EY021520)
- Novartis | Alcon | Alcon Research Institute
- Butler Pioneer Award
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
- Health Sciences › Medicine › Rheumatology › Osteomyelitis and Bone Disorders Research
- Life Sciences › Immunology and Microbiology › Immunology › interferon and immune responses
- Keywords
- optineurin, Paget's disease of bone, type I interferon signaling, osteoclastogenesis, bone remodeling, bone resorption, interferon-beta, IFNAR, alkaline phosphatase, therapeutic target
- MeSH terms
- Animals, Bone and Bones, Bone Marrow, Disease Models, Animal, Female, Interferon Type I, Mice, Inbred C57BL, Osteitis Deformans, Osteoclasts, Osteogenesis, Signal Transduction, Bone Remodeling, Receptors, Interferon, Mice, Knockout, Cell Cycle Proteins, Membrane Transport Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Global deletion of Optineurin results in altered type I IFN signaling and abnormal bone remodeling in a model of Paget’s disease. https://app.cochat.ai/papers/10.1038/s41418-019-0341-6
- The paper
- Wong, S.-W., Huang, B.-W., Hu, X., Ho Kim, E., Kolb, J. P., Padilla, R. J., Xue, P., Wang, L., Oguin, T. H., Miguez, P. A., Tseng, H. C., Ko, C.-C., & Martinez, J. (2020). Global deletion of Optineurin results in altered type I IFN signaling and abnormal bone remodeling in a model of Paget’s disease. Cell Death & Differentiation. https://doi.org/10.1038/s41418-019-0341-6
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.